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Dyeing fungi: amphotericin B based fluorescent
probes for multiplexed imaging†
Assel Baibek,a Muhammed Üçüncü, ab Bryn Short,c Gordon Ramage,d
Annamaria Lilienkampf a and Mark Bradley *a
The clinically used antifungal polyene amphotericin B was conjugated,
via the mycosamine and the aglycon moieties, to fluorophores. The
Cy5 conjugated probe showed selective labelling of fungi in the
presence of bacteria, allowing multiplexed imaging and identification
of microbial species in a co-culture of fungi and Gram-positive and
Gram-negative bacteria.
Current diagnostic methods for infections typically involve sample
collection followed by subsequent culture and microorganism detec-
tion/analysis/characterisation. However, culture-based methods are
inherently slow (even for rapidly growing species) and do not allow
immediate, point of care diagnostics and treatment,1,2 which is
crucial for giving patients the correct antimicrobial agent at the right
time. As a result, patients are often treated empirically with broad-
spectrum antibiotics before confirmed diagnosis, which can con-
tribute to an increase in multidrug resistance.3,4 Various diagnostic
tests differ in their reliability, speed, complexity and cost. Widely
used DNA-based tests (e.g. PCR and microarrays) are extremely
sensitive; however, they are relatively complex requiring trained
personnel, instrumentation, and the design of primers for the
predicted pathogen, while also requiring relatively complex sample
processing and as such typically take 424 h from sample to result.5
Access to these methods is also typically limited in rural areas in
developing countries. Thus, there is an urgent need for rapid and
precise diagnostic techniques.
Optical molecular imaging, using target specific fluorescent
probes, could enable rapid in vivo detection of infection.6–10 Key
is the need for rationally designed fluorescent probes that can
selectively and specifically detect microorganisms in complex
biological scenarios, while such probes could also be applied
in vitro as tools for the rapid diagnosis of samples such as
sputum, urine, and blood. Numerous fluorescent probes have
been designed and used for selective detection of Gram-
positive11–14 and Gram-negative bacteria,7,15 and the detection
of resistance gene products such as b-lactamases.16,17 However,
despite the widespread incidence of fungal infections, there are
only a limited number of probes for the identification of
fungi.6,18–21
Here, fluorescent probes for the selective detection of fungi
over bacteria are reported, with fluorescent dyes conjugated at
two different positions of the widely utilised antifungal agent
amphotericin B (AmB), to allow investigation of the optimal
position for fluorophore conjugation. Attachment of red-emitting
fluorophores removed interference from background autofluo-
rescence (a problem with green fluorescent probes)22 and demon-
strated highly successful, ‘‘wash-free’’ labelling of clinically relevant
strains of fungi, including an AmB-tolerant strain of Candida auris
and biofilm forming fungi, as well as selectivity against both Gram-
negative and positive bacteria. Importantly, an AmB-based probe,
used in conjunction with two bacteria specific probes with different
fluorophores, allowed multiplexed imaging of mixed cultures of
microorganisms.
Amphotericin B (AmB) is a clinically used antifungal agent
that disrupts the cell membrane by binding to ergosterol, a
component that is specific to the fungal cell membrane. It leads
to cell death by the formation of pores that allow uncontrolled
ion leakage. The positively charged amino group in the myco-
samine moiety of AmB has been suggested as being vital for
antifungal activity as it is believed to play a key role in the
interaction with ergosterol;23 however, membrane labelling has
been reported by conjugation of fluorescein to the mycosamine
of AmB through a piperazinyl linker.20 Thus, here both the
carboxylic acid of the aglycon and the amine of the mycosamine
moiety of AmB were conjugated to fluorophores via an amide
bond to ascertain the optimal conjugation position and to
a EaStChem School of Chemistry, The University of Edinburgh, Edinburgh, UK.
E-mail: mark.bradley@ed.ac.uk
b Department of Analytical Chemistry, Faculty of Pharmacy, Izmir Katip Celebi
University, Izmir, Turkey
c The University of the West of Scotland, Institute of Healthcare, Policy and Practice,
Paisley, UK
d School of Medicine, Dentistry and Nursing, College of Medicine, Veterinary and
Life Sciences, University of Glasgow, Glasgow, UK
† Electronic supplementary information (ESI) available: Synthetic schemes, spec-
troscopic and biological data, experimental procedures and characterisation of
compounds. See DOI: 10.1039/d0cc08177a
Received 16th December 2020,






































































































Chem. Commun. This journal is©The Royal Society of Chemistry 2021
clarify the importance of specific functional groups of AmB. Nitro-
benzofurazan (NBD, lex/em = 475/545 nm) and the far-red emitting
sulfonated merocyanine (MeroCy, lex/em = 597/627 nm) were chosen
as fluorophores as their fluorescence increases within hydro-
phobic environments24 such as the cell membrane. Sulfonated
Cy5 (lex/em = 653/671 nm) was also explored as a means of
promoting probe solubility by adding a negatively charged
moiety to the probe. Two different lengths of a polyethylene
glycol (PEG)-based spacer were also investigated – again, as a
means of promoting solubility and to minimise the effect of the
fluorophore on the labelling/binding efficiency of the AmB-
conjugates (Scheme 1).
For the conjugation of the fluorophores to the mycosamine
moiety of AmB, PEG functionalised NBDs 1 and 2 were synthe-
sised (Scheme S1, ESI†) and their corresponding activated
N-hydroxysuccimide (NHS) esters 3 and 4 coupled to AmB to
give probes AmB-NBD-1B and AmB-NBD-2B (Scheme 1). For
coupling to the aglycon moiety of AmB, the carboxylic acid was
activated in situ using PyBOP25 followed by the addition of
amino-PEG functionalised NBD fluorophores 7 and 8, sulfo-
nated MeroCy 12 or Cy5 13 to give AmB-NBD-1A, AmB-NBD-2A,
AmB-MeroCy and AmB-Cy5, respectively. The amine functiona-
lised sulfonated MeroCy was synthesised in three steps.
N-Alkylation of sulfonated indoline 9 with Boc-protected ami-
nohexyl bromide gave 10 in 72% yield, which was subsequently
reacted with benzothiophenone24 11 in the presence of sodium
acetate (mw irradiation at 75 1C) to give the Boc-protected
MeroCy that was deprotected under acidic conditions to give
the amino-functionalised MeroCy 12 (Scheme S3, ESI†). For the
AmB-Cy5 probe, sulfonated Cy526 was converted to the corres-
ponding NHS-ester with HSPyU and coupled to Boc-1-amino-
3,6-dioxa-8-octanediamine, followed by Boc-group cleavage to
give the amino-PEG functionalised Cy5 13 (Scheme S4, ESI†).
The AmB–NBD conjugates were incubated with Candida
albicans (10 mM, 1 h) and the fungi imaged using confocal
microscopy. AmB-NBD-1A and AmB-NBD-2A showed good
labelling of the cell membrane, whereas AmB-NBD-1B and
AmB-NBD-2B showed reduced labelling (Fig. 1), indicating that
the aglycon moiety of AmB was the optimal site of fluorophore
conjugation. Similarly, AmB-MeroCy (10 mM, 2 h) and AmB-Cy5
(10 mM, 1 h) both interacted well with the fungal membrane
(Fig. S2a, ESI†). AmB-NBD-2A and AmB-MeroCy showed an
increase in fluorescence intensity in response to a hydrophobic
environment24 (Fig. S1, ESI†), while AmB-Cy5 was the most
soluble probe. Optimal labelling was observed with the red-
emitting probes AmB-MeroCy (10 mM) and AmB-Cy5 (10 mM)
and were thus used for further studies, for example, imaging
five different clinical isolates of Candida, including the life-
threatening C. auris strain (Fig. 2a and Fig. S2b, S2c, ESI†). All
the Candida strains showed comparable labelling of the fungal
membrane, remarkably, C. auris strain NCPF 8993, which is
AmB tolerant (MIC 1 mg mL1, MFC 432 mg mL1, Table S1,
ESI†), was also efficiently labelled, suggesting that drug resis-
tance does not arise from blockage of interaction of the drug
with the cell membrane. In addition, considering that invasive
fungal infection can be caused not only by yeast forming, but
Scheme 1 Synthesis of the AmB-based probes for the fluorescent labelling of fungi. Fluorophores NBD, MeroCy and Cy5 were conjugated, via a PEG
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also by spore-forming species, strains of Aspergillus fumigatus
and Fusarium solani were evaluated and also showed successful
labelling of the hyphae with both probes (Fig. 2a).
While testing free-flouting planktonic cells provides impor-
tant scientific proof of the probes’ interaction with fungi, in
real life infections most fungal species form and exist within
biofilms.27 In biofilms, fungi aggregate and adhere to each
other expressing an extracellular matrix, making it difficult for
external molecules to penetrate through and interact with the
fungi.28,29 Considering this challenge, fungal biofilms of the
clinical isolate C. auris NCPF 8993 were generated and incubated
with AmB-MeroCy and AmB-Cy5 (10 mM, 2 h), with confocal
images showing uniform labelling of the fungal population
within the biofilms with both probes (Fig. 2b). These results
demonstrate that these AmB-based probes can be used for
detection of fungi not only as planktonic cells, but in the form
of aggregated biofilms.
The lack of ergosterol in the bacterial cell wall should allow
the specific detection of fungi with the AmB-based probes in
the presence of bacteria and, indeed, incubation of Staphylo-
coccus aureus or Escherichia coli with AmB-Cy5 did not show any
bacterial labelling (Fig. 3a). AmB-Cy5 was also used with the
recently reported probe, Vancomycin–MeroCy14 (Van-MeroCy,
which selectively labels Gram-positive bacteria in the presence
of Gram-negative bacteria) and Polymyxin–NBD (PMX-NBD,
which selectively labels Gram-negative bacteria) to demonstrate
multiplexed imaging and identification in a mixed culture – in
essence providing a tool for the rapid detection and distinguishing
Fig. 1 (a) Fluorescent confocal microscopy images (lex = 488 nm) of
C. albicans labelled using the AmB-NBD probes. Fungi were grown in
potato dextrose liquid media overnight, then incubated with the probes
(10 mM in PBS) for 1 h at 37 1C. Scale bar 10 mm. (b) Fluorescent intensities
were quantified by single cell selection on a bright field view and measuring
the mean fluorescent intensities of the raw fluorescent images (for at least
20 cells with the autofluorescence signal (no probe) subtracted). Bars show
the mean fluorescence (SEM).
Fig. 2 (a) Confocal microscopy images of clinically isolated Candida
strains and spore-forming strains of Aspergillus fumigatus and Fusarium
solani labelled with AmB-MeroCy and AmB-Cy5 (10 mM, 2 h at 37 1C). See
ESI,† Fig. S3 full panel of clinical trains tested. (b) Fungal biofilms of clinical
isolate C. auris NCPF 8993 incubated with AmB-MeroCy and AmB-Cy5
(10 mM, 2 h). Scale bar 10 mm.
Fig. 3 Multiplexed imaging of a fungi and bacteria. (a) C. albicans and a
mixed culture of S. aureus and E. coli were incubated with AmB-Cy5
(10 mM) for 1 h at 37 1C. The media was removed, PBS added, and the cells
were imaged at lex = 633 nm. See ESI,† Fig. S6 for the fluorescence plot
profiles. (b) Confocal microscopy images of a live co-culture of fungi
(C. albicans) with Gram-positive bacteria (S. aureus in blue) and Gram-
negative bacteria (E. coli in green). The bacteria and fungi were
co-incubated for 1 h at 37 1C with AmB-Cy5 (10 mM in red) and the
Gram-positive bacteria probe Van-MeroCy14 (1 mM) and Gram-negative
bacteria probe PMX-NBD7 (5 mM). Scale bar 10 mm. See also Movies 1 and 2
(ESI†). For imaging, the cells were simultaneously excited at 488 nm,
561 nm and 633 nm with emission detected in three channels using
automated spectral dye separation. *Due to the spill over of signal from
the MeroCy fluorophore into Cy5 channel image processing was per-
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of three different types of microorganisms in a single sample.
When mixed cultures of C. albicans and Gram-positive and Gram-
negative bacteria (S. aureus and E. coli, respectively) were established
and AmB-Cy5 (10 mM, 1 h) added, highly selective labelling of fungi
was observed (Fig. 3b and Fig. S3, S5, Scheme S5, ESI†), with the
bacterial probes Van-MeroCy and PMX-NBD enabling the selective
labelling of bacteria.
In conclusion, conjugation of fluorophores to the carboxylic
acid of aglycon of antifungal agent amphotericin B gave fluorescent
probes that were able to efficiently label the fungal membrane, also
supporting the observation that the mycosamine moiety is required
for antifungal activity. Development of far-red emitting probes
demonstrated efficient labelling of numerous strains of fungi,
including a number of clinical isolates. Importantly, the probes
also successfully labelled spore-forming fungi, as well as fungi in
biofilms illustrating their versatility. Probes conjugated to the Sulfo-
Cy5 fluorophore were able to selectively label fungi in the presence
of both Gram-positive and Gram-negative bacteria, thus allowing
multiplexed fluorescent labelling in a microbial mixture. Having
this arsenal of highly selective fluorescent probes with different
fluorophores will allow the rapid diagnosis of the source of infec-
tion be it bacterial or fungal in origin.
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